Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 263

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 10
Chunk 263
---
. This summary does not address all U. S. federal income tax matters that may be relevant to a particular U. S. holder, such as the effects of Section 451(b) of the Code. This summary does not address tax considerations applicable to a holder of the ordinary shares or ADSs that may be subject to special tax rules including, without limitation, the following:

• banks, financial institutions or insurance companies;

• brokers, dealers or traders in securities, currencies, commodities, or notional principal contracts;

• tax-exempt entities or organizations, including an “individual retirement account” or “ Roth IRA” as defined in Section 408 or 408A of the Code (as defined below), respectively;

• real estate investment trusts, regulated investment companies or grantor trusts;

• persons that hold the ordinary shares or ADSs as part of a “hedging,” “integrated,” “wash sale” or “conversion” transaction or as a position in a “straddle” for U. S. federal income tax purposes;

• S corporations, partnerships, or other entities or arrangements classified as partnerships, for U. S. federal income tax purposes;

• certain former citizens or long-term residents of the United States;

• persons that received the ordinary shares or ADSs as compensation for the performance of services;

• persons acquiring the ordinary shares or ADSs in connection with a trade or business conducted outside of the United States, including a permanent establishment or a fixed base in France;

• holders that own directly, indirectly, or through attribution 10% or more of the voting power or value of the ordinary shares or ADSs; and

• holders that have a “functional currency” other than the U. S. dollar.

Holders of the ordinary shares or ADSs who fall within one of the categories above are advised to consult their tax advisor regarding the specific tax consequences which may apply to their particular situation.

For the purposes of this description, a “ U. S. holder” is a beneficial owner of the ordinary shares or ADSs that is (or is treated as), for U. S. federal income tax purposes:

• an individual who is a citizen or resident of the United States;

• a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia;

• an estate, the income of which is subject to U. S. federal income taxation regardless of its source; or

• a trust, if a court within the